Results

Total Results: 1,220 records

Showing results for "treatment".

61. Evidence Summary: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-b-virus-infection-screening
    December 15, 2020 - Based on 18 trials (n = 2972), antiviral therapy compared with placebo or no treatment was associated … therapies to achieve intermediate outcomes. … Antiviral Therapy vs Placebo or No Treatment Eighteen trials (n = 2972) reported effects of antiviral … Antiviral Therapy vs Placebo or No Treatment Seven randomized trials of antiviral therapy vs placebo … Antiviral Therapy vs Placebo or No Treatment There were no statistically significant differences between

62. Recommendation: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/obstructive-sleep-apnea-in-adults-screening
    November 15, 2022 - . 4 Mandibular advancement devices (MADs) are an alternative therapy to positive airway pressure for … 16 Surgical interventions for OSA are available, but they generally are not considered first-line treatments … or discomfort. 15 , 16 In general, the adverse events related to positive airway pressure and MAD therapy … The focus of this recommendation is first-line therapies for OSA. … Surgical therapies are typically reserved for patients who do not respond to first-line therapies or

63. JAMA (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/DQgVKNYn6gFtXLfwthuRBU
    June 12, 2020 - Photody- namic therapy, a treatment combining verteporfin (a photoreac- tive agent) and low-level laser … associated with increased risk of most serious adverse events.13 Laser photocoagulation and photodynamic therapy … that re- fractive correction (through corrective lens or surgery) and cataract surgery are effective treatments … participants with intermediate AMD or advanced AMD in 1 eye (OR, 0.73 [99% CI, 0.54-0.99]).13 Other potential therapies … Photodynamic therapy for neovascular age-related macular degeneration.

64. Evidence Summary: Depression and Suicide Risk in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-depression-suicide-risk-adults
    June 20, 2023 - Efficacy of self-guided internet-based cognitive behavioral therapy in the treatment of depressive symptoms … Maternal, fetal, and child outcomes of mental health treatments in women: ameta-analysis of pharmacotherapy … Dialectical behavior therapy as a precursor to PTSD treatment for suicidal and/or self-injuring women … The effect of a therapeutic smartphone application on suicidal ideation in young adults: findings from … Adverse effects of pharmacologic treatments of major depression in older adults.

65. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
    June 09, 2020 - In treatment-seeking populations, opioid agonist therapy and naltrexone were associated with decreased … Retention in substance use treatment was also an outcome for pharmacological therapy. … After 4 to 12 months of treatment, opioid agonist therapy was associated with de- creased risk of relapse … Pharmacological Therapies Opioid Agonist Therapy (Buprenorphine or Methadone) | Four trials of buprenorphine … Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers

66. Final Research Plan: Syphilis Infection During Pregnancy: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/syphilis-infection-pregnant-persons
    March 02, 2023 - What are the harms of treatment of syphilis with penicillin during pregnancy to pregnant persons or newborns … time during pregnancy, who are not known to have syphilis infection KQ 3: Studies of penicillin treatment … in nonpregnant persons; studies of penicillin treatment for any condition other than syphilis … syphilis with a nontreponemal and treponemal test (traditional or reverse sequence algorithms) KQ 3: Treatment … (e.g., false-positive and false-negative results, stigma, and psychosocial harms) KQ 3: Harms of treatment

67. Final Research Plan: Syphilis Infection During Pregnancy: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/syphilis-infection-in-pregnancy-screening
    March 02, 2023 - What are the harms of treatment of syphilis with penicillin during pregnancy to pregnant persons or newborns … time during pregnancy, who are not known to have syphilis infection KQ 3: Studies of penicillin treatment … in nonpregnant persons; studies of penicillin treatment for any condition other than syphilis … syphilis with a nontreponemal and treponemal test (traditional or reverse sequence algorithms) KQ 3: Treatment … (e.g., false-positive and false-negative results, stigma, and psychosocial harms) KQ 3: Harms of treatment

68. Final Research Plan: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obstructive-sleep-apnea-in-adults-screening
    March 04, 2021 - How effective is treatment with positive airway pressure (PAP) or mandibular advancement devices (MADs … How effective is treatment with PAP or MADs for improving health outcomes in persons with OSA, including … What are the harms associated with treatment of OSA using PAP or MADs, including for specific subgroups … of allergic rhinitis or similar treatments that might secondarily improve OSA by treating another condition … In response to public comments, the USPSTF revised the treatment eligibility criteria to clarify the

69. Final Research Plan: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/latent-tuberculosis-infection-screening
    June 17, 2021 - or who had received no more than a few weeks of treatment. … observed therapy for 6 or 9 months, RIF daily for 4 months, or INH plus RPT weekly by directly observed … therapy for 3 months) compared with placebo, no treatment, delayed treatment, or another eligible treatment … KQs 3, 5: Studies comparing other treatments or combinations (i.e., regimens that are not recommended … KQ 4: False-positive results leading to unnecessary testing or treatment, labeling, stigma, anxiety,

70. Depression and Suicide Risk Screening: Updated Evidence Summary and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/zk8YxjaQxLGUTtt__nBQB_
    September 09, 2021 - Efficacy of self-guided internet-based cognitive behavioral therapy in the treatment of depressive symptoms … Maternal, fetal, and child outcomes of mental health treatments in women: a meta-analysis of pharmacotherapy … Dialectical behavior therapy as a precursor to PTSD treatment for suicidal and/or self-injuring women … The effect of a therapeutic smartphone application on suicidal ideation in young adults: findings from … Adverse effects of pharmacologic treatments of major depression in older adults.

71. Recommendation: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/chronic-obstructive-pulmonary-disease-screening
    May 10, 2022 - to stop smoking. 12 Pharmacologic therapies (eg, bronchodilators and anti-inflammatory therapies) … and nonpharmacologic therapies (eg, interventions addressing self-management of disease, diet, exercise … (LABAs), long-acting muscarinic antagonists (LAMAs), inhaled corticosteroids (ICS), or combination therapy … cardiovascular risk association with LABAs or LAMAs was absent, or even reduced, with prevalent use of inhaled therapy … The USPSTF describes the benefits and harms of pharmacologic and nonpharmacologic COPD treatments in

72. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/mggnaKHr496c8QCgHe9-tm
    May 01, 2021 - to stop smoking.12 Pharmacologic therapies (eg, bronchodilators and anti- inflammatory therapies) and … nonpharmacologic therapies (eg, in- terventions addressing self-management of disease, diet, exer- cise … LABAs), long-acting muscarinic an- tagonists (LAMAs), inhaled corticosteroids (ICS), or combination therapy … cardiovascular risk association with LABAs or LAMAs was absent, or even reduced, with prevalent use of inhaled therapy … The USPSTF describes the benefits and harms of pharmacologic and nonpharmacologic COPD treatments in

73. Evidence Summary: Gestational Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/gestational-diabetes-screening
    August 10, 2021 - For benefits of screening and treatment, comparisons were against no screening or treatment, respectively … Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized … multiple gestations, corticosteroid use 30 d prior to enrollment, gastric bypass surgery, use of fertility treatments … OGCT-positive and 1 abnormal value by Carpenter and Coustan criteria 24-28 wGA Group 1: Diet therapy … : No significant association with SGA, low birth weight, neonatal hypoglycemia requiring IV glucose therapy

74. Evidence Summary: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
    May 02, 2023 - persons in the isoniazid-only group, and combination therapy was found to be noninferior. … isoniazid and 1.1% for rifampin. 131 Meta-analysis found no statistically significant difference between treatments … It is unclear whether changes in the prevalence of tuberculosis (which has decreased), treatments for … noninferiority, improved adherence, and lower risk of hepatotoxicity for current, CDC-preferred LTBI treatments … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis

75. Final Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prostate-cancer-screening-adults
    December 21, 2023 - (i.e., what percentage of men initially choose active surveillance or watchful waiting vs. curative treatments … such as surgery, radiation, or ablative therapy)?     … (external beam radiation therapy, proton beam therapy, and brachytherapy) Cryosurgery/high-intensity … focused ultrasonography/other focal ablative therapies Active surveillance ‡ Watchful waiting ‡ … ‡Active surveillance and watchful waiting are typically compared to more active treatments in trials.

76. Archived: Gestational Diabetes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-screening-2008
    May 15, 2008 - There was fair-to-good evidence that screening, combined with therapy for GDM, can reduce the rate of … In contrast, the ACHOIS participants used insulin only if other therapies failed to achieve tight glycemic … and no worse with alternate therapies. … With regard to potential fetal or newborn risks, the potential teratogenicity of certain newer treatments … ; however, most treatments for GDM start in the second trimester, after the period of major organogenesis

77. Recommendation: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/genital-herpes-serologic-screening
    February 14, 2023 - helpful, and repeat serologic testing may be indicated. 4 In symptomatic pregnant persons, antiviral therapy … Sexually transmitted infections treatment guidelines, 2021: genital herpes. … https://www.cdc.gov/std/treatment-guidelines/herpes.htm 4. … Sexually transmitted infections treatment guidelines, 2021. … https://www.cdc.gov/std/treatment/SexualHistory.htm 16.

78. Screening for Asymptomatic Bacteriuria in Adults: Evidence for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/RoC9VuSorM_LR7sTvLeFF2
    July 01, 2008 - Study Selection: For benefits of screening or treatment for screened populations, systematic reviews; … Data Synthesis: An updated Cochrane systematic review of 14 randomized, controlled trials of treatment … After the initial round of therapy, significantly (P � 0.001) more women in the placebo group continued … Men We identified no studies of screening or treatment for asymptomatic bacteriuria in men. 2. … Antimicrobial treatment in diabetic women with asymptomatic bacteriuria.

79. Archived: Evidence Summary: High Blood Pressure in Adults, Children, and Adolescents: Screening, 2003 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/high-blood-pressure-adults-children-adolescents-screening-2003
    April 01, 2003 - Treatment for hypertension has traditionally been defined as pharmacological or nonpharmacological therapy … Pharmacological Treatments for Adults with Hypertension Stage 3 Hypertension. … Nonpharmacological Therapies in Adults RCTs of nonpharmacological therapies have examined CVD events … Additionally, treatment of adult hypertensive patients with drug therapy and possibly nonpharmacological … New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.

80. ahrq29a - Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
    March 01, 2004 - Good Newer treatments have achieved treatment reduce the Well-designed sustained virologic response … with older treatments. Trials were performed in patients referred for treatment. 7b. … Good Common adverse events with intolerance to treatment) Well-designed interferon-based therapy are … Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid … Clinical Therapeutics. 1994;16(2):334–343. 134. Zarski JP, Leroy V.